NRX Pharmaceuticals
NRXP
NRXP
23 hedge funds and large institutions have $16.2M invested in NRX Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $18.9M → $16.2M (-$2.71M)
51% less call options, than puts
Call options by funds: $3.24M | Put options by funds: $6.65M
Holders
23
Holding in Top 10
–
Calls
$3.24M
Puts
$6.65M
Top Buyers
| 1 | +$3.36M | |
| 2 | +$1.42M | |
| 3 | +$1.25M | |
| 4 |
Jane Street
New York
|
+$714K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$513K |
Top Sellers
| 1 | -$4.23M | |
| 2 | -$2.32M | |
| 3 | -$1.52M | |
| 4 |
ICM
Ionic Capital Management
New York
|
-$415K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$139K |